Zinc, Zinc

Zinc is an essential mineral, necessary for all cells in the body. Zinc is concentrated in muscles, bones, skin, kidneys, liver, pancreas, eyes and prostate. It plays an essential role in hundreds of bodily processes. From cell growth to sexual maturation and immunity, even to the senses of taste and smell.

  • Origin: Animal Product, Plant Based, Synthetic
  • Source: Meat, Eggs, Legume, Oysters
  • Type: Mineral
  • Age Range: Adults, Seniors
  • Toxicity: There is no evidence of toxicity until now
  • Outcomes: Bone and Joint Health, Cognitive Function and Brain Health, Energy and Mood, Immunity, Men’s Health, Specific Conditions, Bone Density, Cognitive Enhancer, Depression, Preventive Immunity, Testosterone, Eye Health, Fertility

What are Zinc benefits?

Zinc is one of the essential minerals for the development and maintenance of the body. Since the human body does not produce zinc naturally, it is acquired through food or supplements. Involved in various enzymes, zinc plays an important role in antioxidant enzymes, brain function, and the immune system, as well as other biological parts. It is also worth noting that Zinc is commonly ingested to reduce the frequency of disease and to maintain optimal testosterone levels. Furthermore, according to studies, it has been revealed that the consumption of Zinc brings several benefits, such as: improved immune function, stabilization of blood sugar levels, help in maintaining healthy skin, eyes, and heart, improvement of depression and acne, among others.

Table of relations

Outcome
Sub-Outcome
Consistent effects
Strength of effects
Scientific articles
Bone and Joint Health Bone and Joint Health
Bone Density
See All 5 studies
Cognitive Function and Brain Health Cognitive Function and Brain Health
Cognitive Enhancer
See All 7 studies
Energy and Mood Energy and Mood
Depression
See All 5 studies
Immunity Immunity
Preventive Immunity
See All 8 studies
Men’s Health Men’s Health
Testosterone
See All 4 studies
Specific Conditions Specific Conditions
Eye Health
See All 1 studies
Women’s Health Women’s Health
Fertility
See All 1 studies

Bone and Joint Health Zinc and Bone and Joint Health

Bone and joint health are deeply affected by vitamins, hormones and minerals, such as calcium, vitamin D and thyroid hormones. Supplements that affect bone and joint health help their structure and strength, in addition to contributing to the healthy balance of involved nutraceuticals.

  • Bone Density

    Bone density or bone mineral density (BMD) is the amount of bone mineral in bone tissue. The measurement of bone mineral density is used in medicine as an indirect indicator of osteoporosis and risk of fractures.

Cognitive Function and Brain Health Zinc and Cognitive Function and Brain Health

Cognitive functions are brain skills divided into: memory, perception, language, executive functions, attention and praxis (ability to perform complex movements). These functions depend on healthy synapses and neurons, which require good overall brain functioning. Supplements can affect cognitive performance directly or indirectly. Direct effects can alter or participate in neurotransmissions and influence the brain's energy metabolism. The indirect effects include hormonal changes that affect the brain, and improvements in cognitive disorders such as anxiety, depression and insomnia.

  • Cognitive Enhancer

    Cognition encompasses many factors, such as thinking, language, perception, and memory. When talking about cognitive improvement, we define age-related decline in cognitive health as something common, however, knowing which habits negatively influence it and how to prevent any loss in these areas is important. In addition to age, factors such as injury, family history, or bad habits can influence the decline to some degree of the sectors involved. Several studies associate nutrition with the improvement of brain and cognitive function; the ingestion of nutraceuticals for this purpose optimizes this process and guarantees results with scientific proof.

Energy and Mood Zinc and Energy and Mood

Energy and mood are associated with several external and internal factors. Hormone release, brain chemical balance, nutrient metabolism, and several other elements alter the way the body and mind respond to daily activities. The compounds that benefit energy and mood are the ones that help in the balance of all these factors.

  • Depression

    Depression is a chronic and recurrent psychiatric condition that produces mood changes characterized by deep sadness, mood swings, loss of interest in activities, causing significant impairment in daily life.

Immunity Zinc and Immunity

The immune system is made up of cells, tissues and organs that act in the organism's defense against the harmful effects of external microorganisms. The supplements indicated for immunity act as strengthening agents of this system, increasing the antibodies production and, consequently, its defense activity.

  • Preventive Immunity

    White blood cells - or leukocytes - are the body's defense cells that destroy foreign agents, for example, bacteria, viruses and toxic substances that attack our body and cause infections or other diseases. There are also enzymes that refer to the antioxidant defense system that plays the role of inhibiting and/or reducing the damage caused by the harmful action of free radicals or non-radical reactive species.

Men's Health Zinc and Men's Health

A man's health is the result of various habits throughout his life, such as diet, exercise, vaccinations, routine exams, and family history. Male health has biological differences from female health, such as: hormone levels, sexual life and libido, and the cognitive system. Keeping your body healthy requires discipline and attention to monitoring, because these differences require specific care and solutions for a balanced body. Nutraceuticals can help all areas of man's health to function in harmony, from the extraction of vitamins, minerals, and other substances from nature's plants, fruits, and herbs, they boost the good performance of every part of the body.

  • Testosterone

    Testosterone is the main male sex hormone. It is responsible for regulating fertility, muscle mass, fat distribution and the production of red blood cells. Women's ovaries also produce testosterone, although in much smaller quantities.

Specific Conditions Zinc and Specific Conditions

Specific body conditions categorize precise areas of our body, such as: Respiratory allergies; Liver; Eye health; Blood pressure; Cholesterol and triglycerides; and Blood glucose control. These areas require specific attention because they are delicate functions related to other parts of the body. Respiratory allergies, for example, are linked to the immune system, and to present an effective nutraceutical, we keep our scientific base up to date.

  • Eye Health

    The eyes are very important organs for the quality of life in general. They are extremely sensitive, thus they deserve preventive care because when they are harmed, they are not easily treated. The compounds used for eye health are mainly specific antioxidants and fatty acids.

Zinc and

  • Fertility

    Fertility is the term used to categorize the ability to reproduce easily. There are many problems between men and women regarding fertility, but there are several ways to improve this process. Some compounds can help with it by regulating hormones, for example.

Table of negative interactions

Drugs
Abatacept, Adalimumab, Alefacept, Alendronate, Altegravir, Anakinra, Azathioprine, Baloxavir, Baricitinib, Basiliximab, Belatacept, Belimumab, Betamethasone, Brodalumab, Budesonide, Canakinumab, Certolizumab, Cinoxacin, Ciprofloxacin, Cortisone, Cyclosporine, Daclizumab, Deferiprone, Deflazacort, Delafloxacin, Demeclocycline, Dexamethasone, Dolutegravir, Dupilumab, Durvalumab, Efalizumab, Eltrombopag, Elvitegravir, Enoxacin, Etanercept, Etidronate, Everolimus, Gatifloxacin, Gemifloxacin, Golimumab, Grepafloxacin, Guselkumab, Hydrocortisone, Ibandronate, Inebilizumab, Infliximab, Ixekizumab, Leflunomide, Levofloxacin, Lomefloxacin, Marboxil, Melphalan, Methylprednisolone, Minocycline, Mogamulizumab, Moxifloxacin, Muromonab-Cd3, Natalizumab, Naxitamab, Norfloxacin, Ocrelizumab, Ofloxacin, Omadacycline, Omalizumab, Oxytetracycline, Patiromer, Penicillamine, Prednisolone, Prednisone, Rilonacept, Risankizumab, Risedronate, Rituximab, Sarecycline, Sarilumab, Satralizumab, Secukinumab, Siltuximab, Sirolimus, Sparfloxacin, Tacrolimus, Temsirolimus, Teriflunomide, Tetracycline, Tildrakizumab, Tiludronate, Tocilizumab, Tofacitinib, Triamcinolone, Trientine, Trovafloxacin, Upadacitinib, Ustekinumab, Vedolizumab, Voclosporin
Foods
Bread, Cereals, Rice, Shellfish

Related videos about Zinc

Other Mineral

Calcium

Women's Health Bone and Joint Health

Calcium is an essential mineral, its importance is related to the functions it plays in bone mineralization, especially in bone health, from the fo...

Ver mais

Chromium Picolinate

Specific Conditions

Chromium is a an essential mineral, meaning that it must be obtained from the diet. It serves several important functions in the body. For example,...

Ver mais

Iron

Cognitive Function and Brain Health

Iron is an essential mineral for the body, as it participates in the formation of blood cells and helps in the transport of oxygen. It is also impo...

Ver mais

Magnesium

Specific Conditions Bone and Joint Health

Magnesium is the fourth most abundant mineral in the human body. The nutrient is essential for hundreds of metabolic processes and many other impor...

Ver mais

References

  1. ^ a b Koehler K, et al. Serum testosterone and urinary excretion of steroid hormone metabolites after administration of a high-dose zinc supplement. Eur J Clin Nutr. (2009)
  2. ^ Weismann K, et al. Zinc gluconate lozenges for common cold. A double-blind clinical trial. Dan Med Bull. (1990)
  3. ^ Guéguen M, et al. Shellfish and residual chemical contaminants: hazards, monitoring, and health risk assessment along French coasts. Rev Environ Contam Toxicol. (2011)
  4. ^ Maret W, Sandstead HH. Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol. (2006)
  5. ^ Brown KH, Hambidge KM, Ranum P; Zinc Fortification Working Group. Zinc fortification of cereal flours: current recommendations and research needs. Food Nutr Bull. (2010)
  6. ^ Prasad AS. Zinc: an overview. Nutrition. (1995)
  7. ^ Vallee BL, Falchuk KH. The biochemical basis of zinc physiology. Physiol Rev. (1993)
  8. ^ Haase H, Rink L. Functional significance of zinc-related signaling pathways in immune cells. Annu Rev Nutr. (2009)
  9. ^ Anzellotti AI, Farrell NP. Zinc metalloproteins as medicinal targets. Chem Soc Rev. (2008)
  10. ^ Vallee BL, Auld DS. Zinc metallochemistry in biochemistry. EXS. (1995)
  11. ^ Abreu IA, Cabelli DE. Superoxide dismutases-a review of the metal-associated mechanistic variations. Biochim Biophys Acta. (2010)
  12. ^ Prasad AS. Zinc in human health: effect of zinc on immune cells. Mol Med. (2008)
  13. ^ Prasad AS. Clinical, immunological, anti-inflammatory and antioxidant roles of zinc. Exp Gerontol. (2008)
  14. ^ Nutrient Reference Values for Australia and New Zealand: Zinc.
  15. ^ Recommended Dietary Allowances: 10th Edition.
  16. ^ Prasad AS. Clinical manifestations of zinc deficiency. Annu Rev Nutr. (1985)
  17. ^ Prasad AS. Zinc deficiency in human subjects. Prog Clin Biol Res. (1983)
  18. ^ a b Cope EC, Levenson CW. Role of zinc in the development and treatment of mood disorders. Curr Opin Clin Nutr Metab Care. (2010)
  19. ^ a b Takeda A, Tamano H. Insight into zinc signaling from dietary zinc deficiency. Brain Res Rev. (2009)
  20. ^ Quantifying Selected Major Risks to Health.
  21. ^ Hambidge M. Human zinc deficiency. J Nutr. (2000)
  22. ^ Lukaski HC. Magnesium, zinc, and chromium nutriture and physical activity. Am J Clin Nutr. (2000)
  23. ^ Campbell WW, Anderson RA. Effects of aerobic exercise and training on the trace minerals chromium, zinc and copper. Sports Med. (1987)
  24. ^ Galbo H, et al. Thyroid and testicular hormone responses to graded and prolonged exercise in man. Eur J Appl Physiol Occup Physiol. (1977)
  25. ^ Hackney AC, et al. Comparison of the hormonal responses to exhaustive incremental exercise in adolescent and young adult males. Arq Bras Endocrinol Metabol. (2011)
  26. ^ a b c d Canfield WK, Hambidge KM, Johnson LK. Zinc nutriture in type I diabetes mellitus: relationship to growth measures and metabolic control. J Pediatr Gastroenterol Nutr. (1984)
  27. ^ a b Kinlaw WB, et al. Abnormal zinc metabolism in type II diabetes mellitus. Am J Med. (1983)
  28. ^ a b McNair P, et al. Hyperzincuria in insulin treated diabetes mellitus–its relation to glucose homeostasis and insulin administration. Clin Chim Acta. (1981)
  29. ^ a b Zargar AH, et al. Copper, zinc and magnesium levels in type-1 diabetes mellitus. Saudi Med J. (2002)
  30. ^ a b c d Cellular zinc in patients with diabetes mellitus.
  31. ^ a b c d e Jansen J, et al. Disturbed zinc homeostasis in diabetic patients by in vitro and in vivo analysis of insulinomimetic activity of zinc. J Nutr Biochem. (2012)
  32. ^ a b Aguilar MV, et al. Plasma mineral content in type-2 diabetic patients and their association with the metabolic syndrome. Ann Nutr Metab. (2007)
  33. ^ a b Kiilerich S, et al. 65 zinc absorption in patients with insulin-dependent diabetes mellitus assessed by whole-body counting technique. Clin Chim Acta. (1990)
  34. ^ a b Williams NR, et al. Plasma, granulocyte and mononuclear cell copper and zinc in patients with diabetes mellitus. Analyst. (1995)
  35. ^ a b c Barrie SA, et al. Comparative absorption of zinc picolinate, zinc citrate and zinc gluconate in humans. Agents Actions. (1987)
  36. ^ Korolkiewicz RP, et al. Polaprezinc exerts a salutary effect on impaired healing of acute gastric lesions in diabetic rats. Dig Dis Sci. (2000)
  37. ^ Odenwald MA, Turner JR. Intestinal permeability defects: is it time to treat?. Clin Gastroenterol Hepatol. (2013)
  38. ^ a b c d e Mahmood A, et al. Zinc carnosine, a health food supplement that stabilises small bowel integrity and stimulates gut repair processes. Gut. (2007)
  39. ^ a b Weigand E, Kirchgessner M. Homeostatic adjustments in zinc digestion to widely varying dietary zinc intake. Nutr Metab. (1978)
  40. ^ Effect of dietary zinc on 65-ZN absorption and turnover in rats.
  41. ^ Wada L, Turnlund JR, King JC. Zinc utilization in young men fed adequate and low zinc intakes. J Nutr. (1985)
  42. ^ Lee DY, et al. Homeostasis of zinc in marginal human zinc deficiency: role of absorption and endogenous excretion of zinc. J Lab Clin Med. (1993)
  43. ^ Taylor CM, et al. Homeostatic regulation of zinc absorption and endogenous losses in zinc-deprived men. Am J Clin Nutr. (1991)
  44. ^ Wong CP, Magnusson KR, Ho E. Increased inflammatory response in aged mice is associated with age-related zinc deficiency and zinc transporter dysregulation. J Nutr Biochem. (2012)
  45. ^ Beiseigel JM, et al. Zinc absorption adapts to zinc supplementation in postmenopausal women. J Am Coll Nutr. (2009)
  46. ^ a b Wessells KR, et al. Plasma zinc concentration responds rapidly to the initiation and discontinuation of short-term zinc supplementation in healthy men. J Nutr. (2010)
  47. ^ a b Frederickson CJ, et al. Importance of zinc in the central nervous system: the zinc-containing neuron. J Nutr. (2000)
  48. ^ Barañano DE, Ferris CD, Snyder SH. Atypical neural messengers. Trends Neurosci. (2001)
  49. ^ Choi DW, Koh JY. Zinc and brain injury. Annu Rev Neurosci. (1998)
  50. ^ a b Frederickson CJ, et al. Cytoarchitectonic distribution of zinc in the hippocampus of man and the rat. Brain Res. (1983)
  51. ^ Harrison NL, Gibbons SJ. Zn2+: an endogenous modulator of ligand- and voltage-gated ion channels. Neuropharmacology. (1994)
  52. ^ Palm R, Hallmans G. Zinc concentrations in the cerebrospinal fluid of normal adults and patients with neurological diseases. J Neurol Neurosurg Psychiatry. (1982)
  53. ^ Wensink J, et al. The effect of dietary zinc deficiency on the mossy fiber zinc content of the rat hippocampus. A microbeam PIXE study. Particle Induced X-Ray Emission. Histochemistry. (1987)
  54. ^ a b Baltaci AK, Mogulkoc R. Pinealectomy and melatonin administration in rats: their effects on plasma leptin levels and relationship with zinc. Acta Biol Hung. (2007)
  55. ^ Spontaneous and evoked release of endogenous Zn2+ in the hippocampal mossy fiber zone of the rat in situ.
  56. ^ a b Sensi SL1, Yin HZ, Weiss JH. AMPA/kainate receptor-triggered Zn2+ entry into cortical neurons induces mitochondrial Zn2+ uptake and persistent mitochondrial dysfunction. Eur J Neurosci. (2000)
  57. ^ Dineley KE1, et al. Zinc causes loss of membrane potential and elevates reactive oxygen species in rat brain mitochondria. Mitochondrion. (2005)
  58. ^ a b Peters S, Koh J, Choi DW. Zinc selectively blocks the action of N-methyl-D-aspartate on cortical neurons. Science. (1987)
  59. ^ Bancila V, et al. Zinc inhibits glutamate release via activation of pre-synaptic K channels and reduces ischaemic damage in rat hippocampus. J Neurochem. (2004)
  60. ^ Brambilla P1, et al. Corpus callosum signal intensity in patients with bipolar and unipolar disorder. J Neurol Neurosurg Psychiatry. (2004)
  61. ^ Wu JC1, et al. Magnetic resonance and positron emission tomography imaging of the corpus callosum: size, shape and metabolic rate in unipolar depression. J Affect Disord. (1993)
  62. ^ Reyes-Haro D1, et al. Uptake of serotonin by adult rat corpus callosum is partially reduced by common antidepressants. J Neurosci Res. (2003)
  63. ^ a b García-Colunga J1, et al. Zinc modulation of serotonin uptake in the adult rat corpus callosum. J Neurosci Res. (2005)
  64. ^ Klein AB1, et al. Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol. (2011)
  65. ^ Leal G1, Comprido D, Duarte CB. BDNF-induced local protein synthesis and synaptic plasticity. Neuropharmacology. (2014)
  66. ^ Adlam J1, Zaman R. The role of BDNF and memory in major depressive disorder. Psychiatr Danub. (2013)
  67. ^ a b Xu H1, et al. Lactational zinc deficiency-induced hippocampal neuronal apoptosis by a BDNF-independent TrkB signaling pathway. Hippocampus. (2011)
  68. ^ Travaglia A1, et al. Zinc(II) interactions with brain-derived neurotrophic factor N-terminal peptide fragments: inorganic features and biological perspectives. Inorg Chem. (2013)
  69. ^ a b c d Corona C1, et al. Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction. Cell Death Dis. (2010)
  70. ^ Hwang JJ1, et al. Activation of the Trk signaling pathway by extracellular zinc. Role of metalloproteinases. J Biol Chem. (2005)
  71. ^ a b c d e f Yang Y1, et al. High dose zinc supplementation induces hippocampal zinc deficiency and memory impairment with inhibition of BDNF signaling. PLoS One. (2013)
  72. ^ a b c Solati Z, et al. Zinc monotherapy increases serum brain-derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: A double-blind, randomized, placebo-controlled trial. Nutr Neurosci. (2014)
  73. ^ a b Ranjbar E, et al. Effects of zinc supplementation on efficacy of antidepressant therapy, inflammatory cytokines, and brain-derived neurotrophic factor in patients with major depression. Nutr Neurosci. (2014)
  74. ^ a b Koh JY, et al. The role of zinc in selective neuronal death after transient global cerebral ischemia. Science. (1996)
  75. ^ Choi DW. Zinc neurotoxicity may contribute to selective neuronal death following transient global cerebral ischemia. Cold Spring Harb Symp Quant Biol. (1996)
  76. ^ Lee JM, et al. Zinc translocation accelerates infarction after mild transient focal ischemia. Neuroscience. (2002)
  77. ^ Diener HC, et al. DP-b99, a membrane-activated metal ion chelator, as neuroprotective therapy in ischemic stroke. Stroke. (2008)
  78. ^ Pittenger C, Krystal JH, Coric V. Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder. NeuroRx. (2006)
  79. ^ Chakrabarty K, et al. Glutamatergic dysfunction in OCD. Neuropsychopharmacology. (2005)
  80. ^ Starck G, et al. A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity. J Neural Transm. (2008)
  81. ^ Coric V, et al. Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial. Biol Psychiatry. (2005)
  82. ^ Sayyah M, et al. Evaluation of oral zinc sulfate effect on obsessive-compulsive disorder: a randomized placebo-controlled clinical trial. Nutrition. (2012)
  83. ^ Neurobiology of Zinc-Influenced Eating Behavior.
  84. ^ Tassabehji NM, et al. Zinc deficiency induces depression-like symptoms in adult rats. Physiol Behav. (2008)
  85. ^ a b c d Ohinata K, et al. Orally administered zinc increases food intake via vagal stimulation in rats. J Nutr. (2009)
  86. ^ Jing MY, Sun JY, Wang JF. The effect of peripheral administration of zinc on food intake in rats fed Zn-adequate or Zn-deficient diets. Biol Trace Elem Res. (2008)
  87. ^ Holst B, et al. GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology. (2007)
  88. ^ Inui A, et al. Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ. FASEB J. (2004)
  89. ^ Asakawa A, et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology. (2001)
  90. ^ Arnold LE, et al. Zinc for attention-deficit/hyperactivity disorder: placebo-controlled double-blind pilot trial alone and combined with amphetamine. J Child Adolesc Psychopharmacol. (2011)
  91. ^ Amani R, et al. Correlation between dietary zinc intakes and its serum levels with depression scales in young female students. Biol Trace Elem Res. (2010)
  92. ^ Siwek M, et al. Serum zinc level in depressed patients during zinc supplementation of imipramine treatment. J Affect Disord. (2010)
  93. ^ Maes M, et al. Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol Psychiatry. (1997)
  94. ^ Maes M, et al. Hypozincemia in depression. J Affect Disord. (1994)
  95. ^ a b Tamano H, et al. Behavior in the forced swim test and neurochemical changes in the hippocampus in young rats after 2-week zinc deprivation. Neurochem Int. (2009)
  96. ^ Watanabe M, et al. Susceptibility to stress in young rats after 2-week zinc deprivation. Neurochem Int. (2010)
  97. ^ a b c d Ilouz R, et al. Inhibition of glycogen synthase kinase-3beta by bivalent zinc ions: insight into the insulin-mimetic action of zinc. Biochem Biophys Res Commun. (2002)
  98. ^ Gould TD, et al. Targeting glycogen synthase kinase-3 in the CNS: implications for the development of new treatments for mood disorders. Curr Drug Targets. (2006)
  99. ^ Little KY, et al. Altered zinc metabolism in mood disorder patients. Biol Psychiatry. (1989)
  100. ^ Sawada T, Yokoi K. Effect of zinc supplementation on mood states in young women: a pilot study. Eur J Clin Nutr. (2010)
  101. ^ Stewart-Knox BJ, et al. Supplemented zinc does not alter mood in healthy older European adults–a randomised placebo-controlled trial: the Zenith study. Public Health Nutr. (2011)
  102. ^ Siwek M, et al. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study. J Affect Disord. (2009)
  103. ^ a b c Tahmasebi Boroujeni S, et al. The effect of severe zinc deficiency and zinc supplement on spatial learning and memory. Biol Trace Elem Res. (2009)
  104. ^ a b c Flinn JM1, et al. Enhanced zinc consumption causes memory deficits and increased brain levels of zinc. Physiol Behav. (2005)
  105. ^ Mizuno M1, et al. Involvement of BDNF receptor TrkB in spatial memory formation. Learn Mem. (2003)
  106. ^ Piechal A1, et al. Maternal zinc supplementation improves spatial memory in rat pups. Biol Trace Elem Res. (2012)
  107. ^ Railey AM1, et al. Alterations in fear response and spatial memory in pre- and post-natal zinc supplemented rats: remediation by copper. Physiol Behav. (2010)
  108. ^ Aquilani R, et al. Normalization of zinc intake enhances neurological retrieval of patients suffering from ischemic strokes. Nutr Neurosci. (2009)
  109. ^ Hennig B, Toborek M, Mcclain CJ. Antiatherogenic properties of zinc: implications in endothelial cell metabolism. Nutrition. (1996)
  110. ^ Beattie JH, Kwun IS. Is zinc deficiency a risk factor for atherosclerosis. Br J Nutr. (2004)
  111. ^ Yang YJ, et al. Dietary zinc intake is inversely related to subclinical atherosclerosis measured by carotid intima-media thickness. Br J Nutr. (2010)
  112. ^ Bao B, et al. Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent. Am J Clin Nutr. (2010)
  113. ^ a b c Kelishadi R, et al. Effect of zinc supplementation on markers of insulin resistance, oxidative stress, and inflammation among prepubescent children with metabolic syndrome. Metab Syndr Relat Disord. (2010)
  114. ^ Jansen J, Karges W, Rink L. Zinc and diabetes–clinical links and molecular mechanisms. J Nutr Biochem. (2009)
  115. ^ Eldar-Finkelman H, Krebs EG. Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action. Proc Natl Acad Sci U S A. (1997)
  116. ^ Correlation between zinc status and immune function in the elderly.
  117. ^ Meftah S, et al. Ecto 5′ nucleotidase (5’NT) as a sensitive indicator of human zinc deficiency. J Lab Clin Med. (1991)
  118. ^ a b c Blostein-Fujii A, et al. Short-term zinc supplementation in women with non-insulin-dependent diabetes mellitus: effects on plasma 5′-nucleotidase activities, insulin-like growth factor I concentrations, and lipoprotein oxidation rates in vitro. Am J Clin Nutr. (1997)
  119. ^ Hashemipour M, et al. Effect of zinc supplementation on insulin resistance and components of the metabolic syndrome in prepubertal obese children. Hormones (Athens). (2009)
  120. ^ Seet RC, et al. Oral zinc supplementation does not improve oxidative stress or vascular function in patients with type 2 diabetes with normal zinc levels. Atherosclerosis. (2011)
  121. ^ a b c d e f g Mantzoros CS, et al. Zinc may regulate serum leptin concentrations in humans. J Am Coll Nutr. (1998)
  122. ^ a b c Prasad AS, et al. Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr. (2007)
  123. ^ The Dynamic Link between the Integrity of the Immune System and Zinc Status.
  124. ^ Chandra RK. Excessive intake of zinc impairs immune responses. JAMA. (1984)
  125. ^ a b c Singh M, Das RR. Zinc for the common cold. Cochrane Database Syst Rev. (2011)
  126. ^ Ganguly A, et al. A randomized controlled trial of oral zinc in acute pneumonia in children aged between 2 months to 5 years. Indian J Pediatr. (2011)
  127. ^ Wadhwa N, et al. Efficacy of zinc given as an adjunct in the treatment of severe and very severe pneumonia in hospitalized children 2-24 mo of age: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. (2013)
  128. ^ a b Valentiner-Branth P, et al. A randomized controlled trial of the effect of zinc as adjuvant therapy in children 2-35 mo of age with severe or nonsevere pneumonia in Bhaktapur, Nepal. Am J Clin Nutr. (2010)
  129. ^ Shah GS, et al. Role of zinc in severe pneumonia: a randomized double bind placebo controlled study. Ital J Pediatr. (2012)
  130. ^ a b c Srinivasan MG, et al. Zinc adjunct therapy reduces case fatality in severe childhood pneumonia: a randomized double blind placebo-controlled trial. BMC Med. (2012)
  131. ^ Basnet S, et al. A randomized controlled trial of zinc as adjuvant therapy for severe pneumonia in young children. Pediatrics. (2012)
  132. ^ Valavi E, et al. The efficacy of zinc supplementation on outcome of children with severe pneumonia. A randomized double-blind placebo-controlled clinical trial. Indian J Pediatr. (2011)
  133. ^ Chandyo RK, et al. Two weeks of zinc administration to Nepalese children with pneumonia does not reduce the incidence of pneumonia or diarrhea during the next six months. J Nutr. (2010)
  134. ^ Baum MK, et al. HIV-1 infection in women is associated with severe nutritional deficiencies. J Acquir Immune Defic Syndr Hum Retrovirol. (1997)
  135. ^ Beach RS, et al. Specific nutrient abnormalities in asymptomatic HIV-1 infection. AIDS. (1992)
  136. ^ Jones CY, et al. Micronutrient levels and HIV disease status in HIV-infected patients on highly active antiretroviral therapy in the Nutrition for Healthy Living cohort. J Acquir Immune Defic Syndr. (2006)
  137. ^ Graham NM, et al. Relationship of serum copper and zinc levels to HIV-1 seropositivity and progression to AIDS. J Acquir Immune Defic Syndr. (1991)
  138. ^ Falutz J, Tsoukas C, Gold P. Zinc as a cofactor in human immunodeficiency virus-induced immunosuppression. JAMA. (1988)
  139. ^ Baum MK, et al. Zinc status in human immunodeficiency virus type 1 infection and illicit drug use. Clin Infect Dis. (2003)
  140. ^ Tang AM, et al. Dietary micronutrient intake and risk of progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men. Am J Epidemiol. (1993)
  141. ^ Baum MK, et al. Randomized, controlled clinical trial of zinc supplementation to prevent immunological failure in HIV-infected adults. Clin Infect Dis. (2010)
  142. ^ Mocchegiani E, et al. Benefit of oral zinc supplementation as an adjunct to zidovudine (AZT) therapy against opportunistic infections in AIDS. Int J Immunopharmacol. (1995)
  143. ^ Han YS, et al. Papain-like protease 2 (PLP2) from severe acute respiratory syndrome coronavirus (SARS-CoV): expression, purification, characterization, and inhibition. Biochemistry. (2005)
  144. ^ Hsu JT, et al. Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV. FEBS Lett. (2004)
  145. ^ Kara E, et al. Effect of zinc supplementation on antioxidant activity in young wrestlers. Biol Trace Elem Res. (2010)
  146. ^ Chang CS, et al. Correlation between serum testosterone level and concentrations of copper and zinc in hair tissue. Biol Trace Elem Res. (2011)
  147. ^ Prasad AS, et al. Zinc status and serum testosterone levels of healthy adults. Nutrition. (1996)
  148. ^ Zeng Q, et al. Associations of urinary metal concentrations and circulating testosterone in Chinese men. Reprod Toxicol. (2013)
  149. ^ Lei KY, Abbasi A, Prasad AS. Function of pituitary-gonadal axis in zinc-deficient rats. Am J Physiol. (1976)
  150. ^ a b Om AS, Chung KW. Dietary zinc deficiency alters 5 alpha-reduction and aromatization of testosterone and androgen and estrogen receptors in rat liver. J Nutr. (1996)
  151. ^ Chung KW, et al. Androgen receptors in ventral prostate glands of zinc deficient rats. Life Sci. (1986)
  152. ^ Habib FK. Zinc and the steroid endocrinology of the human prostate. J Steroid Biochem. (1978)
  153. ^ Kaya O, et al. Zinc supplementation in rats subjected to acute swimming exercise: Its effect on testosterone levels and relation with lactate. Neuro Endocrinol Lett. (2006)
  154. ^ a b Sankako MK, et al. Possible mechanism by which zinc protects the testicular function of rats exposed to cigarette smoke. Pharmacol Rep. (2012)
  155. ^ Jalali GR, et al. Impact of oral zinc therapy on the level of sex hormones in male patients on hemodialysis. Ren Fail. (2010)
  156. ^ a b c d Netter A, Hartoma R, Nahoul K. Effect of zinc administration on plasma testosterone, dihydrotestosterone, and sperm count. Arch Androl. (1981)
  157. ^ a b Shafiei Neek L, Gaeini AA, Choobineh S. Effect of zinc and selenium supplementation on serum testosterone and plasma lactate in cyclist after an exhaustive exercise bout. Biol Trace Elem Res. (2011)
  158. ^ a b Kilic M, et al. The effect of exhaustion exercise on thyroid hormones and testosterone levels of elite athletes receiving oral zinc. Neuro Endocrinol Lett. (2006)
  159. ^ Kilic M. Effect of fatiguing bicycle exercise on thyroid hormone and testosterone levels in sedentary males supplemented with oral zinc. Neuro Endocrinol Lett. (2007)
  160. ^ a b c d e Stamatiadis D, Bulteau-Portois MC, Mowszowicz I. Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid. Br J Dermatol. (1988)
  161. ^ Fahim MS, et al. Zinc arginine, a 5 alpha-reductase inhibitor, reduces rat ventral prostate weight and DNA without affecting testicular function. Andrologia. (1993)
  162. ^ a b Leake A, Chisholm GD, Habib FK. The effect of zinc on the 5 alpha-reduction of testosterone by the hyperplastic human prostate gland. J Steroid Biochem. (1984)
  163. ^ a b Sugimoto Y, et al. Cations inhibit specifically type I 5 alpha-reductase found in human skin. J Invest Dermatol. (1995)
  164. ^ a b Cesur Y, Yordaman N, Doğan M. Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels in children with zinc deficiency and the effect of zinc supplementation on these parameters. J Pediatr Endocrinol Metab. (2009)
  165. ^ Rodondi A, et al. Zinc increases the effects of essential amino acids-whey protein supplements in frail elderly. J Nutr Health Aging. (2009)
  166. ^ Konukoglu D, et al. Relationship between plasma leptin and zinc levels and the effect of insulin and oxidative stress on leptin levels in obese diabetic patients. J Nutr Biochem. (2004)
  167. ^ Ott ES, Shay NF. Zinc deficiency reduces leptin gene expression and leptin secretion in rat adipocytes. Exp Biol Med (Maywood). (2001)
  168. ^ Kwun IS, et al. Marginal zinc deficiency in rats decreases leptin expression independently of food intake and corticotrophin-releasing hormone in relation to food intake. Br J Nutr. (2007)
  169. ^ Saladin R, et al. Transient increase in obese gene expression after food intake or insulin administration. Nature. (1995)
  170. ^ Grunfeld C, et al. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest. (1996)
  171. ^ Beck FW, et al. Changes in cytokine production and T cell subpopulations in experimentally induced zinc-deficient humans. Am J Physiol. (1997)
  172. ^ Human Zinc Deficiency.
  173. ^ Gustin concentration changes relative to salivary zinc and taste in humans.
  174. ^ Heyneman CA. Zinc deficiency and taste disorders. Ann Pharmacother. (1996)
  175. ^ Tupe RP, Chiplonkar SA. Zinc supplementation improved cognitive performance and taste acuity in Indian adolescent girls. J Am Coll Nutr. (2009)
  176. ^ Mahmoodi MR, Kimiagar SM. Prevalence of zinc deficiency in junior high school students of Tehran City. Biol Trace Elem Res. (2001)
  177. ^ Hettiarachchi M, et al. Prevalence and severity of micronutrient deficiency: a cross-sectional study among adolescents in Sri Lanka. Asia Pac J Clin Nutr. (2006)
  178. ^ a b Lyckholm L, et al. A randomized, placebo controlled trial of oral zinc for chemotherapy-related taste and smell disorders. J Pain Palliat Care Pharmacother. (2012)
  179. ^ Uçkardeş Y, et al. The effect of systemic zinc supplementation on oral health in low socioeconomic level children. Turk J Pediatr. (2009)
  180. ^ Kirchhoff P, et al. Zinc salts provide a novel, prolonged and rapid inhibition of gastric acid secretion. Am J Gastroenterol. (2011)
  181. ^ Sturniolo GC, et al. Inhibition of gastric acid secretion reduces zinc absorption in man. J Am Coll Nutr. (1991)
  182. ^ Loguercio C, et al. Trace elements and chronic liver diseases. J Trace Elem Med Biol. (1997)
  183. ^ a b Nakayama A, et al. A new diagnostic method for chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma based on serum metallothionein, copper, and zinc levels. Biol Pharm Bull. (2002)
  184. ^ Lin CC, et al. Selenium, iron, copper, and zinc levels and copper-to-zinc ratios in serum of patients at different stages of viral hepatic diseases. Biol Trace Elem Res. (2006)
  185. ^ Nutritional Status and Blood Trace Elements in Cirrhotic Patients.
  186. ^ a b Somi MH, et al. Effects of low dose zinc supplementation on biochemical markers in non-alcoholic cirrhosis: a randomized clinical trial. Arch Iran Med. (2012)
  187. ^ Sturniolo GC, et al. Zinc supplementation tightens “leaky gut” in Crohn’s disease. Inflamm Bowel Dis. (2001)
  188. ^ Zinc Supplementation Inhibits Hepatic Apoptosis in Mice Subjected to a Long-Term Ethanol Exposure.
  189. ^ Preservation of Intestinal Structural Integrity by Zinc Is Independent of Metallothionein in Alcohol-Intoxicated Mice.
  190. ^ Zhou Z, et al. Zinc supplementation prevents alcoholic liver injury in mice through attenuation of oxidative stress. Am J Pathol. (2005)
  191. ^ Zinc Deficiency Mediates Alcohol-Induced Alveolar Epithelial and Macrophage Dysfunction in Rats.
  192. ^ Kang YJ, Zhou Z. Zinc prevention and treatment of alcoholic liver disease. Mol Aspects Med. (2005)
  193. ^ Kang WS, et al. Effects of a zinc-deficient diet on hearing in CBA mice. Neuroreport. (2012)
  194. ^ Hoeve LJ, Wensink J, Mertens zur Borg IR. Hearing loss related to zinc deficiency in rats. Eur Arch Otorhinolaryngol. (1990)
  195. ^ Franco-Vidal V, et al. Zinc protection against pneumolysin toxicity on rat cochlear hair cells. Audiol Neurootol. (2008)
  196. ^ a b Coelho CB, Tyler R, Hansen M. Zinc as a possible treatment for tinnitus. Prog Brain Res. (2007)
  197. ^ Sha SH, et al. Overexpression of copper/zinc-superoxide dismutase protects from kanamycin-induced hearing loss. Audiol Neurootol. (2001)
  198. ^ Shambaugh GE Jr. Zinc for tinnitus, imbalance, and hearing loss in the elderly. Am J Otol. (1986)
  199. ^ a b Arda HN, et al. The role of zinc in the treatment of tinnitus. Otol Neurotol. (2003)
  200. ^ Ochi K, et al. Zinc deficiency and tinnitus. Auris Nasus Larynx. (2003)
  201. ^ Yetiser S, et al. The role of zinc in management of tinnitus. Auris Nasus Larynx. (2002)
  202. ^ Yang CH, et al. Zinc in the treatment of idiopathic sudden sensorineural hearing loss. Laryngoscope. (2011)
  203. ^ Kumari D, Nair N, Bedwal RS. Testicular apoptosis after dietary zinc deficiency: ultrastructural and TUNEL studies. Syst Biol Reprod Med. (2011)
  204. ^ Clegg MS, et al. Zinc deficiency-induced cell death. IUBMB Life. (2005)
  205. ^ Nodera M, Yanagisawa H, Wada O. Increased apoptosis in a variety of tissues of zinc-deficient rats. Life Sci. (2001)
  206. ^ Kumari D, Nair N, Bedwal RS. Protein carbonyl, 3β-, and 17β-hydroxysteroid dehydrogenases in testes and serum FSH, LH, and testosterone levels in zinc deficient Wistar rats. Biofactors. (2012)
  207. ^ Bahuguna A, Bedwal RS. Testicular protein profile (SDS-PAGE) study of zinc deficient Wistar albino rat. Indian J Exp Biol. (2008)
  208. ^ Kumari D, Nair N, Bedwal RS. Effect of dietary zinc deficiency on testes of Wistar rats: Morphometric and cell quantification studies. J Trace Elem Med Biol. (2011)
  209. ^ Merrells KJ, et al. Relationship between abnormal sperm morphology induced by dietary zinc deficiency and lipid composition in testes of growing rats. Br J Nutr. (2009)
  210. ^ Croxford TP, McCormick NH, Kelleher SL. Moderate zinc deficiency reduces testicular Zip6 and Zip10 abundance and impairs spermatogenesis in mice. J Nutr. (2011)
  211. ^ Yamaguchi S, et al. Zinc is an essential trace element for spermatogenesis. Proc Natl Acad Sci U S A. (2009)
  212. ^ Sangthawan D, Phungrassami T, Sinkitjarurnchai W. A randomized double-blind, placebo-controlled trial of zinc sulfate supplementation for alleviation of radiation-induced oral mucositis and pharyngitis in head and neck cancer patients. J Med Assoc Thai. (2013)
  213. ^ Saadeh CE. Chemotherapy- and radiotherapy-induced oral mucositis: review of preventive strategies and treatment. Pharmacotherapy. (2005)
  214. ^ Mansouri A, et al. The effect of zinc sulfate in the prevention of high-dose chemotherapy-induced mucositis: a double-blind, randomized, placebo-controlled study. Hematol Oncol. (2012)
  215. ^ Arbabi-kalati F, et al. Evaluation of the efficacy of zinc sulfate in the prevention of chemotherapy-induced mucositis: a double-blind randomized clinical trial. Arch Iran Med. (2012)
  216. ^ Ertekin MV, et al. Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: a prospective, placebo-controlled, randomized study. Int J Radiat Oncol Biol Phys. (2004)
  217. ^ Halyard MY. Taste and smell alterations in cancer patients–real problems with few solutions. J Support Oncol. (2009)
  218. ^ Hong JH, et al. Taste and odor abnormalities in cancer patients. J Support Oncol. (2009)
  219. ^ Henkin RI, Martin BM, Agarwal RP. Decreased parotid saliva gustin/carbonic anhydrase VI secretion: an enzyme disorder manifested by gustatory and olfactory dysfunction. Am J Med Sci. (1999)
  220. ^ a b Henkin RI, Martin BM, Agarwal RP. Efficacy of exogenous oral zinc in treatment of patients with carbonic anhydrase VI deficiency. Am J Med Sci. (1999)
  221. ^ Dreno B, et al. Acne: evolution of the clinical practice and therapeutic management of acne between 1996 and 2000. Eur J Dermatol. (2003)
  222. ^ Ozuguz P, et al. Evaluation of serum vitamins A and E and zinc levels according to the severity of acne vulgaris. Cutan Ocul Toxicol. (2013)
  223. ^ Michaëlsson G, Vahlquist A, Juhlin L. Serum zinc and retinol-binding protein in acne. Br J Dermatol. (1977)
  224. ^ Nasiri S, et al. Serum zinc levels in Iranian patients with acne. Clin Exp Dermatol. (2009)
  225. ^ a b Leibovici V, et al. Effect of zinc therapy on neutrophil chemotaxis in psoriasis. Isr J Med Sci. (1990)
  226. ^ Dreno B, et al. Zinc salts effects on granulocyte zinc concentration and chemotaxis in acne patients. Acta Derm Venereol. (1992)
  227. ^ Göransson K, Lidén S, Odsell L. Oral zinc in acne vulgaris: a clinical and methodological study. Acta Derm Venereol. (1978)
  228. ^ Verma KC, Saini AS, Dhamija SK. Oral zinc sulphate therapy in acne vulgaris: a double-blind trial. Acta Derm Venereol. (1980)
  229. ^ Dreno B, et al. Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris. Dermatology. (2001)
  230. ^ Dreno B, et al. Low doses of zinc gluconate for inflammatory acne. Acta Derm Venereol. (1989)
  231. ^ Mun JH, et al. Oral zinc sulfate treatment for viral warts: an open-label study. J Dermatol. (2011)
  232. ^ Al-Gurairi FT, Al-Waiz M, Sharquie KE. Oral zinc sulphate in the treatment of recalcitrant viral warts: randomized placebo-controlled clinical trial. Br J Dermatol. (2002)
  233. ^ a b Sharquie KE, Khorsheed AA, Al-Nuaimy AA. Topical zinc sulphate solution for treatment of viral warts. Saudi Med J. (2007)
  234. ^ Chapter 43. Rosacea, Perioral Dermatitis and Similar Dermatoses, Flushing and Flushing Syndromes.
  235. ^ Sharquie KE, Najim RA, Al-Salman HN. Oral zinc sulfate in the treatment of rosacea: a double-blind, placebo-controlled study. Int J Dermatol. (2006)
  236. ^ Bamford JT, et al. Randomized, double-blind trial of 220 mg zinc sulfate twice daily in the treatment of rosacea. Int J Dermatol. (2012)
  237. ^ Crutchfield CE 3rd, Lewis EJ, Zelickson BD. The highly effective use of topical zinc pyrithione in the treatment of psoriasis: a case report. Dermatol Online J. (1997)
  238. ^ Sadeghian G, Ziaei H, Nilforoushzadeh MA. Treatment of localized psoriasis with a topical formulation of zinc pyrithione. Acta Dermatovenerol Alp Panonica Adriat. (2011)
  239. ^ a b Kashefi F1, et al. Comparison of the effect of ginger and zinc sulfate on primary dysmenorrhea: a placebo-controlled randomized trial. Pain Manag Nurs. (2014)
  240. ^ a b Boom A1, et al. Bimodal modulation of tau protein phosphorylation and conformation by extracellular Zn2+ in human-tau transfected cells. Biochim Biophys Acta. (2009)
  241. ^ Mo ZY1, et al. Low micromolar zinc accelerates the fibrillization of human tau via bridging of Cys-291 and Cys-322. J Biol Chem. (2009)
  242. ^ Cuajungco MP1, Fagét KY. Zinc takes the center stage: its paradoxical role in Alzheimer’s disease. Brain Res Brain Res Rev. (2003)
  243. ^ Bush AI1, Tanzi RE. Therapeutics for Alzheimer’s disease based on the metal hypothesis. Neurotherapeutics. (2008)
  244. ^ Harris LA, et al. Celiac disease: clinical, endoscopic, and histopathologic review. Gastrointest Endosc. (2012)
  245. ^ Rostom A, et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology. (2005)
  246. ^ Singhal N, et al. Serum zinc levels in celiac disease. Indian Pediatr. (2008)
  247. ^ Solomons NW, Rosenberg IH, Sandstead HH. Zinc nutrition in celiac sprue. Am J Clin Nutr. (1976)
  248. ^ Rawal P, et al. Zinc supplementation to patients with celiac disease–is it required. J Trop Pediatr. (2010)
  249. ^ Najafabadi MM, et al. Zinc sulfate for relief of pruritus in patients on maintenance hemodialysis. Ther Apher Dial. (2012)
  250. ^ Wilborn CD, et al. Effects of Zinc Magnesium Aspartate (ZMA) Supplementation on Training Adaptations and Markers of Anabolism and Catabolism. J Int Soc Sports Nutr. (2004)
  251. ^ Roehrborn CG, et al. Effects of finasteride on serum testosterone and body mass index in men with benign prostatic hyperplasia. Urology. (2003)
  252. ^ Uddin RK, Singh SM. Ethanol-responsive genes: identification of transcription factors and their role in metabolomics. Pharmacogenomics J. (2007)
  253. ^ Carey LC, et al. Maternal ethanol exposure is associated with decreased plasma zinc and increased fetal abnormalities in normal but not metallothionein-null mice. Alcohol Clin Exp Res. (2000)
  254. ^ Carey LC, et al. Ethanol decreases zinc transfer to the fetus in normal but not metallothionein-null mice. Alcohol Clin Exp Res. (2000)
  255. ^ Carey LC, et al. Zinc supplementation at the time of ethanol exposure ameliorates teratogenicity in mice. Alcohol Clin Exp Res. (2003)
  256. ^ Summers BL, Rofe AM, Coyle P. Dietary zinc supplementation throughout pregnancy protects against fetal dysmorphology and improves postnatal survival after prenatal ethanol exposure in mice. Alcohol Clin Exp Res. (2009)
  257. ^ Summers BL, et al. Dietary zinc supplementation during pregnancy prevents spatial and object recognition memory impairments caused by early prenatal ethanol exposure. Behav Brain Res. (2008)
  258. ^ Summers BL, Rofe AM, Coyle P. Prenatal zinc treatment at the time of acute ethanol exposure limits spatial memory impairments in mouse offspring. Pediatr Res. (2006)
  259. ^ Gunshin H, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. (1997)
  260. ^ Tandy S, et al. Nramp2 expression is associated with pH-dependent iron uptake across the apical membrane of human intestinal Caco-2 cells. J Biol Chem. (2000)
  261. ^ Olivares M, et al. Acute inhibition of iron bioavailability by zinc: studies in humans. Biometals. (2012)
  262. ^ Olivares M, Pizarro F, Ruz M. New insights about iron bioavailability inhibition by zinc. Nutrition. (2007)
  263. ^ Olivares M, Pizarro F, Ruz M. Zinc inhibits nonheme iron bioavailability in humans. Biol Trace Elem Res. (2007)
  264. ^ Friel JK, et al. Elevated intakes of zinc in infant formulas don not interfere with iron absorption in premature infants. J Pediatr Gastroenterol Nutr. (1998)
  265. ^ Olivares M, et al. Effect of increasing concentrations of zinc on the absorption of iron from iron-fortified milk. Biol Trace Elem Res. (2012)
  266. ^ a b Willis MS, et al. Zinc-induced copper deficiency: a report of three cases initially recognized on bone marrow examination. Am J Clin Pathol. (2005)
  267. ^ Afrin LB. Fatal copper deficiency from excessive use of zinc-based denture adhesive. Am J Med Sci. (2010)
  268. ^ Nations SP, et al. Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease. Neurology. (2008)
  269. ^ Cousins RJ. Metallothionein–aspects related to copper and zinc metabolism. J Inherit Metab Dis. (1983)
  270. ^ Induction of Kidney Metallothionein and Metallothionein Messenger RNA by Zinc and Cadmium.
  271. ^ Brewer GJ. Copper excess, zinc deficiency, and cognition loss in Alzheimer’s disease. Biofactors. (2012)
  272. ^ Brewer GJ. Copper toxicity in Alzheimer’s disease: cognitive loss from ingestion of inorganic copper. J Trace Elem Med Biol. (2012)
  273. Rashidi AA, et al. Effects of zinc supplementation on serum zinc and C-reactive protein concentrations in hemodialysis patients. J Ren Nutr. (2009)
  274. Hemilä H. Zinc lozenges and the common cold: a meta-analysis comparing zinc acetate and zinc gluconate, and the role of zinc dosage. JRSM Open. (2017)
  275. Jafari F, Amani R, Tarrahi MJ. Effect of Zinc Supplementation on Physical and Psychological Symptoms, Biomarkers of Inflammation, Oxidative Stress, and Brain-Derived Neurotrophic Factor in Young Women with Premenstrual Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial. Biol Trace Elem Res. (2019)
  276. Siahbazi S, et al. Effect of zinc sulfate supplementation on premenstrual syndrome and health-related quality of life: Clinical randomized controlled trial. J Obstet Gynaecol Res. (2017)
  277. Eby GA, Davis DR, Halcomb WW. Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study. Antimicrob Agents Chemother. (1984)
  278. Smith DS, et al. Failure of zinc gluconate in treatment of acute upper respiratory tract infections. Antimicrob Agents Chemother. (1989)
  279. Godfrey JC, et al. Zinc gluconate and the common cold: a controlled clinical study. J Int Med Res. (1992)
  280. Mossad SB, et al. Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study. Ann Intern Med. (1996)
  281. Prasad AS, et al. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. (2000)
  282. Prasad AS, et al. Duration and severity of symptoms and levels of plasma interleukin-1 receptor antagonist, soluble tumor necrosis factor receptor, and adhesion molecules in patients with common cold treated with zinc acetate. J Infect Dis. (2008)
  283. Turner RB, Cetnarowski WE. Effect of treatment with zinc gluconate or zinc acetate on experimental and natural colds. Clin Infect Dis. (2000)
  284. Hemilä H, et al. Zinc acetate lozenges for the treatment of the common cold: a randomised controlled trial. BMJ Open. (2020)
  285. Al-Nakib W, et al. Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. J Antimicrob Chemother. (1987)
  286. Farr BM, et al. Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds. Antimicrob Agents Chemother. (1987)
  287. Ebben M, Lequerica A, Spielman A. Effects of pyridoxine on dreaming: a preliminary study. Percept Mot Skills. (2002)
  288. De Souza MC, et al. A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B6 for the relief of anxiety-related premenstrual symptoms: a randomized, double-blind, crossover study. J Womens Health Gend Based Med. (2000)
  289. Maggio M, et al. The Interplay between Magnesium and Testosterone in Modulating Physical Function in Men. Int J Endocrinol. (2014)
  290. Maggio M, et al. Magnesium and anabolic hormones in older men. Int J Androl. (2011)
  291. Rodgers S, et al. Serum testosterone levels and symptom-based depression subtypes in men. Front Psychiatry. (2015)
  292. Johnson JM, Nachtigall LB, Stern TA. The effect of testosterone levels on mood in men: a review. Psychosomatics. (2013)
  293. Bassil N, Alkaade S, Morley JE. The benefits and risks of testosterone replacement therapy: a review. Ther Clin Risk Manag. (2009)
  294. Zarrouf FA, et al. Testosterone and depression: systematic review and meta-analysis. J Psychiatr Pract. (2009)
  295. Davis SR, Wahlin-Jacobsen S. Testosterone in women–the clinical significance. Lancet Diabetes Endocrinol. (2015)
  296. Martínez-Cengotitabengoa M, González-Pinto A. Nutritional supplements in depressive disorders. Actas Esp Psiquiatr. (2017)
  297. Cortese BM, Phan KL. The role of glutamate in anxiety and related disorders. CNS Spectr. (2005)
  298. Bergink V, van Megen HJ, Westenberg HG. Glutamate and anxiety. Eur Neuropsychopharmacol. (2004)
  299. Tarleton EK, Littenberg B. Magnesium intake and depression in adults. J Am Board Fam Med. (2015)
  300. Derom ML, et al. Magnesium and depression: a systematic review. Nutr Neurosci. (2013)
  301. Boyle NB, Lawton C, Dye L. The Effects of Magnesium Supplementation on Subjective Anxiety and Stress-A Systematic Review. Nutrients. (2017)
  302. Fard FE, et al. Effects of zinc and magnesium supplements on postpartum depression and anxiety: A randomized controlled clinical trial. Women Health. (2017)
  303. Phelan D, et al. Magnesium and mood disorders: systematic review and meta-analysis. BJPsych Open. (2018)
  304. Nielsen FH, Lukaski HC. Update on the relationship between magnesium and exercise. Magnes Res. (2006)
  305. Costello RB, Moser-Veillon PB. A review of magnesium intake in the elderly. A cause for concern?. Magnes Res. (1992)
  306. Tang YM, et al. Relationships between micronutrient losses in sweat and blood pressure among heat-exposed steelworkers. Ind Health. (2016)
  307. Institute of Medicine (US) Committee on Military Nutrition Research; Marriott BM, editor. Washington (DC). Nutritional Needs in Hot Environments, “Influence of Exercise and Heat on Magnesium Metabolism”. National Academies Press (US). (1993)
  308. Consolazio CF, et al. Excretion of sodium, potassium, magnesium and iron in human sweat and the relation of each to balance and requirements. J Nutr. (1963)
  309. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride, page 242.
  310. Yoshimura Y, et al. Pharmacokinetic Studies of Orally Administered Magnesium Oxide in Rats. Yakugaku Zasshi. (2017)
  311. Firoz M, Graber M. Bioavailability of US commercial magnesium preparations. Magnes Res. (2001)
  312. Li Z, et al. Association of total zinc, iron, copper and selenium intakes with depression in the US adults. J Affect Disord. (2018)
  313. Roy A, et al. Higher zinc intake buffers the impact of stress on depressive symptoms in pregnancy. Nutr Res. (2010)
  314. Ranjbar E, et al. Effects of zinc supplementation in patients with major depression: a randomized clinical trial. Iran J Psychiatry. (2013)
  315. Swardfager W, et al. Potential roles of zinc in the pathophysiology and treatment of major depressive disorder. Neurosci Biobehav Rev. (2013)
  316. Nowak G, et al. Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study. Pol J Pharmacol. (2003)
  317. Institute of Medicine (US) Panel on Micronutrients. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc.
  318. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc, page 446.
  319. Meunier N, et al. Importance of zinc in the elderly: the ZENITH study. Eur J Clin Nutr. (2005)
  320. Blumberg J. Nutritional needs of seniors. J Am Coll Nutr. (1997)
  321. Tipton K, et al. Zinc loss in sweat of athletes exercising in hot and neutral temperatures. Int J Sport Nutr. (1993)
  322. Parker GB, Brotchie H, Graham RK. Vitamin D and depression. J Affect Disord. (2017)
  323. Allan GM, et al. Vitamin D: A Narrative Review Examining the Evidence for Ten Beliefs. J Gen Intern Med. (2016)
  324. Nair R, Maseeh A. Vitamin D: The “sunshine” vitamin. J Pharmacol Pharmacother. (2012)
  325. Holick MF. Vitamin D deficiency. N Engl J Med. (2007)
  326. Forrest KY, Stuhldreher WL. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res. (2011)
  327. Melrose S. Seasonal Affective Disorder: An Overview of Assessment and Treatment Approaches. Depress Res Treat. (2015)
  328. Kerr DC, et al. Associations between vitamin D levels and depressive symptoms in healthy young adult women. Psychiatry Res. (2015)
  329. O’Hare C, et al. Seasonal and meteorological associations with depressive symptoms in older adults: A geo-epidemiological study. J Affect Disord. (2016)
  330. Golden RN, et al. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry. (2005)
  331. Lam RW, et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. Am J Psychiatry. (2006)
  332. Vellekkatt F, Menon V. Efficacy of vitamin D supplementation in major depression: A meta-analysis of randomized controlled trials. J Postgrad Med. (2018)
  333. Spedding S. Vitamin D and depression: a systematic review and meta-analysis comparing studies with and without biological flaws. Nutrients. (2014)
  334. Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, et al. Dietary Reference Intakes for Calcium and Vitamin D.
  335. Cashman KD, et al. Improved Dietary Guidelines for Vitamin D: Application of Individual Participant Data (IPD)-Level Meta-Regression Analyses. Nutrients. (2017)
  336. Heaney R, et al. Letter to Veugelers, P.J. and Ekwaru, J.P., A statistical error in the estimation of the recommended dietary allowance for vitamin D. Nutrients 2014, 6, 4472-4475; doi:10.3390/nu6104472. Nutrients. (2015)
  337. Veugelers PJ, Ekwaru JP. A statistical error in the estimation of the recommended dietary allowance for vitamin D. Nutrients. (2014)
  338. Grosso G, et al. Dietary n-3 PUFA, fish consumption and depression: A systematic review and meta-analysis of observational studies. J Affect Disord. (2016)
  339. Mocking RJ, et al. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder. Transl Psychiatry. (2016)
  340. Burhani MD, Rasenick MM. Fish oil and depression: The skinny on fats. J Integr Neurosci. (2017)
  341. Bastiaansen JA, et al. The efficacy of fish oil supplements in the treatment of depression: food for thought. Transl Psychiatry. (2016)
  342. Lane K, et al. Bioavailability and potential uses of vegetarian sources of omega-3 fatty acids: a review of the literature. Crit Rev Food Sci Nutr. (2014)
  343. Hussein N, et al. Long-chain conversion of 13Clinoleic acid and alpha-linolenic acid in response to marked changes in their dietary intake in men. J Lipid Res. (2005)
  344. Pawlosky RJ, et al. Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. J Lipid Res. (2001)
  345. Fokkema MR, et al. Short-term supplementation of low-dose gamma-linolenic acid (GLA), alpha-linolenic acid (ALA), or GLA plus ALA does not augment LCP omega 3 status of Dutch vegans to an appreciable extent. Prostaglandins Leukot Essent Fatty Acids. (2000)
  346. Emken EA, Adlof RO, Gulley RM. Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males. Biochim Biophys Acta. (1994)
  347. Protein and Amino Acid Requirements in Human Nutrition, page 245, table 49.
  348. Jenkins TA, et al. Influence of Tryptophan and Serotonin on Mood and Cognition with a Possible Role of the Gut-Brain Axis. Nutrients. (2016)
  349. Cowen PJ, Browning M. What has serotonin to do with depression?. World Psychiatry. (2015)
  350. Feder A, et al. Tryptophan depletion and emotional processing in healthy volunteers at high risk for depression. Biol Psychiatry. (2011)
  351. Richard DM, et al. L-Tryptophan: Basic Metabolic Functions, Behavioral Research and Therapeutic Indications. Int J Tryptophan Res. (2009)
  352. Young SN, Leyton M. The role of serotonin in human mood and social interaction. Insight from altered tryptophan levels. Pharmacol Biochem Behav. (2002)
  353. Lindseth G, Helland B, Caspers J. The effects of dietary tryptophan on affective disorders. Arch Psychiatr Nurs. (2015)
  354. Kroes MC, et al. Food can lift mood by affecting mood-regulating neurocircuits via a serotonergic mechanism. Neuroimage. (2014)
  355. Møller SE, Kirk L, Honoré P. Relationship between plasma ratio of tryptophan to competing amino acids and the response to L-tryptophan treatment in endogenously depressed patients. J Affect Disord. (1980)
  356. Travison TG, et al. The relationship between libido and testosterone levels in aging men. J Clin Endocrinol Metab. (2006)
  357. Chrysohoou C, et al. Low total testosterone levels are associated with the metabolic syndrome in elderly men: the role of body weight, lipids, insulin resistance, and inflammation; the Ikaria study. Rev Diabet Stud. (2013)
  358. Westley CJ, Amdur RL, Irwig MS. High Rates of Depression and Depressive Symptoms among Men Referred for Borderline Testosterone Levels. J Sex Med. (2015)
  359. Giltay EJ, et al. Salivary testosterone: associations with depression, anxiety disorders, and antidepressant use in a large cohort study. J Psychosom Res. (2012)
  360. Feldman HA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab. (2002)
  361. Wu FC, et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab. (2008)
  362. Handelsman DJ, et al. Age-specific population centiles for androgen status in men. Eur J Endocrinol. (2015)
  363. Cote KA, et al. Sleep deprivation lowers reactive aggression and testosterone in men. Biol Psychol. (2013)
  364. Leproult R, Van Cauter E. Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA. (2011)
  365. Penev PD. Association between sleep and morning testosterone levels in older men. Sleep. (2007)
  366. González-Santos MR, et al. Sleep deprivation and adaptive hormonal responses of healthy men. Arch Androl. (1989)
  367. Cortés-Gallegos V, et al. Sleep deprivation reduces circulating androgens in healthy men. Arch Androl. (1983)
  368. Nedeltcheva AV, et al. Insufficient sleep undermines dietary efforts to reduce adiposity. Ann Intern Med. (2010)
  369. O’Leary CB, Hackney AC. Acute and chronic effects of resistance exercise on the testosterone and cortisol responses in obese males: a systematic review. Physiol Res. (2014)
  370. Kraemer WJ, Ratamess NA. Hormonal responses and adaptations to resistance exercise and training. Sports Med. (2005)
  371. Daly W, et al. Relationship between stress hormones and testosterone with prolonged endurance exercise. Eur J Appl Physiol. (2005)
  372. Hackney AC, Aggon E. Chronic Low Testosterone Levels in Endurance Trained Men: The Exercise- Hypogonadal Male Condition. J Biochem Physiol. (2018)
  373. Grossmann M. Low testosterone in men with type 2 diabetes: significance and treatment. J Clin Endocrinol Metab. (2011)
  374. Tajar A, et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab. (2010)
  375. Hall SA, et al. Correlates of low testosterone and symptomatic androgen deficiency in a population-based sample. J Clin Endocrinol Metab. (2008)
  376. Grossmann M, Matsumoto AM. A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management. J Clin Endocrinol Metab. (2017)
  377. Corona G, et al. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. Eur J Endocrinol. (2013)
  378. Camacho EM, et al. Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study. Eur J Endocrinol. (2013)
  379. Pilz S, et al. Effect of vitamin D supplementation on testosterone levels in men. Horm Metab Res. (2011)
  380. Wehr E, et al. Association of vitamin D status with serum androgen levels in men. Clin Endocrinol (Oxf). (2010)
  381. Uwitonze AM, Razzaque MS. Role of Magnesium in Vitamin D Activation and Function. J Am Osteopath Assoc. (2018)
  382. Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride.
  383. Gonzales-Arimborgo C, et al. Acceptability, Safety, and Efficacy of Oral Administration of Extracts of Black or Red Maca (Lepidium meyenii) in Adult Human Subjects: A Randomized, Double-Blind, Placebo-Controlled Study. Pharmaceuticals (Basel). (2016)
  384. Zenico T, et al. Subjective effects of Lepidium meyenii (Maca) extract on well-being and sexual performances in patients with mild erectile dysfunction: a randomised, double-blind clinical trial. Andrologia. (2009)
  385. Gonzales GF, et al. Effect of Lepidium meyenii (MACA) on sexual desire and its absent relationship with serum testosterone levels in adult healthy men. Andrologia. (2002)
  386. Dording CM, et al. A double-blind placebo-controlled trial of maca root as treatment for antidepressant-induced sexual dysfunction in women. Evid Based Complement Alternat Med. (2015)
  387. G. D’Aniello, et al. D-asparate, a key element for the improvement of sperm quality. Advances in Sexual Medicine. (2012)
  388. Topo E, et al. The role and molecular mechanism of D-aspartic acid in the release and synthesis of LH and testosterone in humans and rats. Reprod Biol Endocrinol. (2009)
  389. Melville GW, Siegler JC, Marshall PW. Three and six grams supplementation of d-aspartic acid in resistance trained men. J Int Soc Sports Nutr. (2015)
  390. Willoughby DS, Leutholtz B. D-aspartic acid supplementation combined with 28 days of heavy resistance training has no effect on body composition, muscle strength, and serum hormones associated with the hypothalamo-pituitary-gonadal axis in resistance-trained men. Nutr Res. (2013)